<Insert Picture Here>

Healthcare and Life Sciences Mission & Strategy

Leo LiangVice PresidentHSGBU Japan and APAC

The following is intended to outline our general product direction. It is intended for information

purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any

material, code, or functionality, and should not be relied upon in making purchasing decisions.The development, release, and timing of any

features or functionality described for Oracle’s products remains at the sole discretion of Oracle.

Oracle Corporation

• World’s largest enterprise software vendor

• Four product families• Applications, Database, Middleware, and

Infrastructure

• $22.4 billion revenue, FY08

• 325,000 global customers

• 85,000 employees

• Operating in 145 countries

Oracle’s Leadership in Health Sciences

Use Oracle Applications to RunTheir Business

Use Oracle Applications to RunTheir Business

Use Oracle Applications to RunTheir Business

Use Oracle Applications to RunTheir Business

Use Oracle Applications to RunTheir Business

20 of the Top 20 Pharmaceutical Companies

8 of the Top 10 Contract Research Organizations

9 of the Top 10 Medical Device Companies

10 of the Top 10 Research Universities

10 of the Top 10 Healthcare Organizations

Total RecallSOA Suite

Audit VaultApps Integration Arch

Business Process Mgmt Self-Managing Database Grid ComputingOracle Data Guard

Real Application ClustersFirst Comprehensive

CRM SuiteFlashback Query

First Internet ApplicationsBuilt-in Java VM

Partitioning SupportFull Applications

Implementation MethodologyIndustry-Specific Business Applications

Object Relational SupportMultimedia Support

Data Warehousing OptimizationsFirst Unix-Based Applications

Parallel OperationDistributed SQL & Transaction SupportCluster & MPP Support

Total RecallSOA Suite

Audit VaultApps Integration Arch

Business Process Mgmt Self-Managing Database Grid ComputingOracle Data Guard

Real Application ClustersFirst Comprehensive

CRM SuiteFlashback Query

First Internet ApplicationsBuilt-in Java VM

Partitioning SupportFull Applications

Implementation MethodologyIndustry-Specific Business Applications

Object Relational SupportMultimedia Support

Data Warehousing OptimizationsFirst Unix-Based Applications

Parallel OperationDistributed SQL & Transaction SupportCluster & MPP Support

Multi-Version Read ConsistencyClient/Server Support

Platform PortabilityCommercial SQL Implementation

• 1,500 Patents• 1,500 Patents in Progress

1970’s… 2000…1980’s… 1990’s…

30 Years of R&D Innovation

$1.3 $1.5$1.9

$2.2

R&D Spending, $B20% CAGR $2.7

FY08FY04 FY05 FY06 FY07

Growth Through AcquisitionCreating Best-in-Business Capabilities

Oracle FY 2005 Oracle FY 2006 Oracle FY 2007 Oracle FY 2008

4 Acquisitions 17 Acquisitions 14 Acquisitions 8 Acquisitions

More Value Less Complexity

More Flexibility Less Cost

More Choice Less Risk

Comprehensive Industry Portfolio

Standards-Based Architecture

Designed toWork Together

Complete Open Integrated

Oracle’s Application Strategy

HSGBU Mission

Our Missionis to be the leading strategic supplier of software solutions to

pharmaceutical, biotech, medical device, and healthcare companies.

discover, develop, and successfully market innovativeproducts and services to:

We will help them

• prevent and cure disease

• enhance quality of life

• and meet their shareholder and stakeholder expectations.

HSGBU Strategy

Our Strategyis to grow to #1 market share for Health Sciences applications

among the largest and/or fastest growing pharmaceutical, biotech,

medical device, and integrated delivery networks worldwide by

offering an integrated application suite sold and supported through

a global ecosystem that provides customers with the industry’s

highest return on investment and best ownership experience.

“Accelerating Insights for Better Health”

Oracle Life Sciences FootprintComplete. Open. Integrated.

CRM & Marketing

Sales Order Mgmt Field Service Samples MgmtCall CenterLoyaltyMarketing

Analytics Business Operations

Clinical Analytics

Operational Analytics

Scientific Analytics

Statistical Analysis

Clinical Development

Data Integration

EDC

Safety

IVRSAMC-Driven Trials

ePROTrial Operations

Trial Design/Setup

Modeling/Simulation

Bio-Specimen MgmtPharmacovigilance

Lab Info Mgmt (LIMS)

Pre-Clinical/Discovery

Clinical Mfg

Pre-Clinical Dev

Scientific Cont. Mgmt

ManufacturingData Mgmt/Collaboration Supply Chain

Image Management

Terminology Services

Clinical Data Mgmt Content Mgmt & Regulatory Submission

Research Collaboration/Grids

Clinical Portfolio Mgmt ePedigree

Supply Chain Planning

Warehouse Management

PLM Sourcing

ERP

Process Operations

Discrete Mfg

Process Mfg

Corporate Administration

Infrastructure

Integration & Collaboration Enterprise Infrastructure

Compensation Facilities Contracts Procurement HR Help DeskFinancialsEPM IT Help DeskHuman Resources

Oracle Partner

The Growing Industry Interdependence Between Healthcare and Life Sciences

Personalized medicineBio-marker discovery

Safety and PharmacovigilanceSubmissions

Pharma/Biotech

Adaptive Clinical Trials

ResearchNetworks

Healthcare Institutions

ClinicalResearch

Labs & Biobanks

CareDelivery

Submission

Enabling Personalized MedicineLinking Biomedical Research to Healthcare

Innovation

Operations

EDC

Imaging

Safety

Clinical Mfg

CTMS

Laboratory

LIFE SCIENCES SOLUTION INTEGRATED SUITE

Pharmacovigilance

Scientific Analytics

Operational Analytics

Simulation & Modeling

Portfolio Analysis

DataManagement

Study Design

ClinicalTrial Sites

Labs &Biobanks

Pharma/Biotech

CRO

Scientific Inference

Oracle’s Current Clinical Development and Safety Applications

Clinical Trial Management(Siebel Clinical)

Electronic Data Capture(Oracle Remote Data Capture)

Clinical Data Management System

(Oracle Clinical)

PharmacovigilanceReporting & Call Center

(Oracle Adverse Event Reporting System)

Term Classification/Dictionary Management(Oracle Thesaurus Management System)

Clinical Integration, Warehousing, & Reporting(Oracle Life Sciences Data Hub)

China will be Top 5 in Pharmaceutical Market by 2010

USA 91

Japan 52

Germany 20

France 18

Italy 10

Brazil 8.4

UK 8.2

Spain 6.0

South Korea 4.5

Canada 4.3

China 4.3

USA 150

Japan 58

Germany 17

France 17

UK 11

Italy 11

China 6.8

Brazil 6.7

Canada 6.3

Spain 6.2

USA 262

Japan 65

Germany 24

France 21

UK 16

Italy 15

China 13

Brazil 10

Canada 10

Spain 9.8

USA 466

Japan 81

Germany 37

France 28

China 25

UK 24

Italy 23

Canada 17

Spain 16

Brazil 15

1996 2000 2005 2010E

Top

10

Pharmaceutical market size (US$B)Source: The Boston Consulting Group

China’s Changing Pharmaceutical Market Profile

Source: International Federation of Pharmaceutical Manufacturers Association

Patented21%

Branded Generics

19%Generics

37%

OTC23%

OTC15%

Generics62%

Branded Generics

14%

Patented9%

+8%+12%+4%

-25%

Chinese pharmaceuticals market profile 2000 Chinese pharmaceuticals market profile 2010 forecast

China Pharmaceutical Market

•Double digits GDP growth during the past decade year after year

•Generic drug market share will drop 25% in 10 years from 2000 to 2010

•Patented drug market share will grow from 9% to 21% from 2000 to 2010

•Huge patient pool, ~250M

•Strategic, supportive government policies and investments

China healthcare market kept a constant growth and a continuous demand for new medicinal products.

Health Sciences Global Management TeamNeil de Crescenzo

GM

Mike McCannN. America LS Sales

Jonathan BestEMEA Sales

Leo LiangAPAC Sales

Kris JoshiStrategy & Business Dev

Ramlal WaghrayDevelopment

Greg JonesArchitecture

Nick GiannasiLS Product Strategy

Penny LieHC Product Strategy

Michele BecciStrategic Accounts

Mark McCourtN. America HC Sales

Dave BunkerAlliances

Sales, Consulting, and Marketing

Product Management

Business Operations

Patrick KesselringSales Operations

Chris IbellGlobal Consulting

Sean FordGlobal Marketing

Thank you!A Win / Win for You and Us.

Thank you!

A Win / Win for You and Us.

Oracle’s HSGBU Clinical Development and Safety Strategy

Expand sales, marketing, partner, and consulting infrastructureNew license and deployment models

Go-to-Market Excellence

Current Applications

NO COMMON PLATFORMNO COMMON PLATFORM

FEATURE SET FOR SINGULAR FEATURE SET FOR SINGULAR BUSINESS PROCESSESBUSINESS PROCESSES

AIA & Composite Applications

ANALYTICSANALYTICS

COMPOSITE APPLICATIONSCOMPOSITE APPLICATIONSUSING AIA: STUDY DESIGN, USING AIA: STUDY DESIGN,

INVESTIGATOR PORTALINVESTIGATOR PORTAL

Next-Generation Integrated Suite (HSS)

NEW INTEGRATED SUITENEW INTEGRATED SUITE

INTEGRATION PLUS NEWINTEGRATION PLUS NEWFEATURES FOR ENDFEATURES FOR END--TOTO--ENDEND

BUSINESS PROCESSESBUSINESS PROCESSES